Related Experiment Video

Updated: Jul 15, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF

Leisl M Packer1, Sandra J Pavey, Glen M Boyle

  • 1Oncogenomics Laboratory, Queensland Institute of Medical Research, Brisbane, Australia. Leisl.Packer@qimr.edu.au

International Journal of Cancer
|April 24, 2007
PubMed

Insights

p14ARF inactivation in melanoma disrupts cell growth pathways. Researchers identified novel downstream targets, including FLRT3, RUNX2, MIG-6, and SMURF2, crucial for melanoma development when p14ARF is lost.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The tumor suppressor p14ARF is frequently inactivated in various cancers, including melanoma.
  • p14ARF regulates cell growth through both p53-dependent and p53-independent pathways.

Purpose of the Study:

  • To identify novel downstream effectors of p14ARF in melanoma.
  • To understand the molecular mechanisms contributing to melanoma development upon p14ARF loss.

Main Methods:

  • Gene expression profiling (microarray) of 35 melanoma cell lines (12 wild-type p14ARF, 23 mutant p14ARF).
  • Bioinformatic pathway analysis of differentially expressed genes.
  • Validation of candidate targets using p14ARF-inducible cell lines and RNA interference (RNAi).

Main Results:

  • Identified 1,316 significantly differentially expressed probe sets between wild-type and mutant p14ARF melanoma cell lines (p < 0.01).
  • Pathway analysis revealed enrichment of receptor-mediated signal transduction pathways (e.g., TGFbeta, EGF, MAPK, Wnt).
  • Confirmed FLRT3, RUNX2, MIG-6, and SMURF2 as direct downstream targets of p14ARF.

Conclusions:

  • Loss of p14ARF function in melanoma leads to dysregulation of critical signaling pathways.
  • The identified downstream targets (FLRT3, RUNX2, MIG-6, SMURF2) play a role in melanoma pathogenesis.
  • These findings highlight potential therapeutic targets for melanoma with p14ARF inactivation.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...